Amgen Inc. Cedear Logo

Amgen Inc. Cedear (AMGN)

BCBA

Currency in ARS
23,290.00
+380.00 (+1.66%)

Real-time Data

02:00 PM

Day's Range

23,010.00
23,300.00

52 wk Range

12,320.00
23,320.00

Profile - AMGN - Amgen Inc. Cedear

Profile

Mic Code

XBUE

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

31.50K


Amgen Inc. is a leading biotechnology company that specializes in the discovery, development, and commercialization of innovative human therapeutics. With its headquarters in Thousand Oaks, California, Amgen has a prominent role in the life sciences sector, focusing on advancing medicines for serious illnesses. The company's primary purpose is to harness the power of cellular and molecular biology to provide treatments for grievous conditions such as cancer, kidney disease, rheumatoid arthritis, and bone disease. Noteworthy for its pioneering work in biotechnology, Amgen develops a wide range of biopharmaceuticals designed to enhance patient care and outcomes. The company has a robust pipeline of new medicines and has contributed significantly to the advancement of biological therapies. Its market significance is underscored by its position as one of the largest independent biotechnology firms in the world. Amgen's products are widely utilized across healthcare settings, and its innovations continue to have a profound impact on the pharmaceutical industry, shaping the future of therapeutic interventions globally.

Profile Details

Type

Depositary Receipt

Ceo

Mr. Robert A. Bradway

Address

One Amgen Center Drive

City

Thousand Oaks

State

CA

Zip

91320-1799

Country

United States

Phone

805 447 1000

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.